These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11174330)

  • 1. Different expressivity of a ventricular essential myosin light chain gene Ala57Gly mutation in familial hypertrophic cardiomyopathy.
    Lee W; Hwang TH; Kimura A; Park SW; Satoh M; Nishi H; Harada H; Toyama J; Park JE
    Am Heart J; 2001 Feb; 141(2):184-9. PubMed ID: 11174330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy.
    Kabaeva ZT; Perrot A; Wolter B; Dietz R; Cardim N; Correia JM; Schulte HD; Aldashev AA; Mirrakhimov MM; Osterziel KJ
    Eur J Hum Genet; 2002 Nov; 10(11):741-8. PubMed ID: 12404107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.
    Nomura A; Tada H; Teramoto R; Konno T; Hodatsu A; Won HH; Kathiresan S; Ino H; Fujino N; Yamagishi M; Hayashi K
    J Cardiol; 2016 Feb; 67(2):133-9. PubMed ID: 26443374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Missense Mutation p.Gly162Glu of the Gene MYL2 Involved in Hypertrophic Cardiomyopathy: A Pedigree Analysis of a Proband.
    Renaudin P; Janin A; Millat G; Chevalier P
    Mol Diagn Ther; 2018 Apr; 22(2):219-223. PubMed ID: 29549657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy.
    Flavigny J; Richard P; Isnard R; Carrier L; Charron P; Bonne G; Forissier JF; Desnos M; Dubourg O; Komajda M; Schwartz K; Hainque B
    J Mol Med (Berl); 1998 Mar; 76(3-4):208-14. PubMed ID: 9535554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy.
    Nakajima-Taniguchi C; Matsui H; Fujio Y; Nagata S; Kishimoto T; Yamauchi-Takihara K
    J Mol Cell Cardiol; 1997 Feb; 29(2):839-43. PubMed ID: 9140840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients.
    Konno T; Shimizu M; Ino H; Matsuyama T; Yamaguchi M; Terai H; Hayashi K; Mabuchi T; Kiyama M; Sakata K; Hayashi T; Inoue M; Kaneda T; Mabuchi H
    J Am Coll Cardiol; 2003 Mar; 41(5):781-6. PubMed ID: 12628722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene mutations in apical hypertrophic cardiomyopathy.
    Arad M; Penas-Lado M; Monserrat L; Maron BJ; Sherrid M; Ho CY; Barr S; Karim A; Olson TM; Kamisago M; Seidman JG; Seidman CE
    Circulation; 2005 Nov; 112(18):2805-11. PubMed ID: 16267253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden.
    Mörner S; Richard P; Kazzam E; Hellman U; Hainque B; Schwartz K; Waldenström A
    J Mol Cell Cardiol; 2003 Jul; 35(7):841-9. PubMed ID: 12818575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population.
    Jääskeläinen P; Soranta M; Miettinen R; Saarinen L; Pihlajamäki J; Silvennoinen K; Tikanoja T; Laakso M; Kuusisto J
    J Am Coll Cardiol; 1998 Nov; 32(6):1709-16. PubMed ID: 9822100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death.
    Konno T; Shimizu M; Ino H; Fujino N; Uchiyama K; Mabuchi T; Sakata K; Kaneda T; Fujita T; Masuta E; Mabuchi H
    Clin Sci (Lond); 2006 Jan; 110(1):125-31. PubMed ID: 16181148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy.
    Nishi H; Kimura A; Harada H; Koga Y; Adachi K; Matsuyama K; Koyanagi T; Yasunaga S; Imaizumi T; Toshima H
    Circulation; 1995 Jun; 91(12):2911-5. PubMed ID: 7796500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations.
    Marian AJ; Mares A; Kelly DP; Yu QT; Abchee AB; Hill R; Roberts R
    Eur Heart J; 1995 Mar; 16(3):368-76. PubMed ID: 7789380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
    Niimura H; Bachinski LL; Sangwatanaroj S; Watkins H; Chudley AE; McKenna W; Kristinsson A; Roberts R; Sole M; Maron BJ; Seidman JG; Seidman CE
    N Engl J Med; 1998 Apr; 338(18):1248-57. PubMed ID: 9562578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain.
    Bundgaard H; Havndrup O; Andersen PS; Larsen LA; Brandt NJ; Vuust J; Kjeldsen K; Christiansen M
    J Mol Cell Cardiol; 1999 Apr; 31(4):745-50. PubMed ID: 10329202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile hypertrophic cardiomyopathy associated with a novel MYL3 mutation.
    Jay A; Chikarmane R; Poulik J; Misra VK
    Cardiology; 2013; 124(4):248-51. PubMed ID: 23594557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.